HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV
Background: In order to develop a more effective prophylactic HIV-1 vaccine it is important optimize the components, improve Envelope glycoprotein immunogenicity as well as to explore prime-boost immunization schedules. It is also valuable to include several HIV-1 subtype antigens representing the w...
Príomhchruthaitheoirí: | , , , , , , , , , , , , , , , , , |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Elsevier
2017-06-01
|
Sraith: | Heliyon |
Ábhair: | |
Rochtain ar líne: | http://www.sciencedirect.com/science/article/pii/S2405844017306655 |